Greatview Aseptic Packaging Company Limited: 2024 Annual Report – Detailed Analysis for Investors

Greatview Aseptic Packaging Company Limited has released its 2024 Annual Report, unveiling a series of critical developments, investigations, internal control reforms, and significant events that are highly material and likely to impact shareholder value and share price. Below is an in-depth review, highlighting the most price-sensitive disclosures and key takeaways for investors.

1. Key Financial and Operational Highlights

• Financial Results: Annual results for the year ended 31 December 2024 are detailed in the Consolidated Statement of Profit or Loss. However, the financial statements received a disclaimer of opinion from the independent auditor due to significant unresolved matters and insufficient audit evidence. This is a serious red flag for investors, casting doubt on the reliability of the reported figures.
• Dividends: The Board recommended and paid a final dividend of HK\$0.22 per share (approx. RMB286.7 million) for 2024, significantly higher than the previous year (HK\$0.06 per share). The dividend was paid out of distributable profits and share premium account, as approved by shareholders.
• Public Float Issue: Following a share transfer, public float fell to just 2.24%, resulting in a suspension of trading in the Company’s shares from 19 February 2025 until the public float is restored to at least 25%. The Company is seeking a waiver from strict compliance, but risks delisting if not resolved by 18 August 2026.
• Gearing: The Group’s gearing ratio stood at 3% (down from 5% in 2023), indicating a strong capital position but overshadowed by the auditor’s disclaimer.

2. Major Corporate Events and Price-Sensitive Issues

2.1. Restructuring and Legal Proceedings

• Restructuring and Deemed Disposal: The Company undertook a high-profile restructuring, involving the subscription of a limited partnership interest in a Fund and the deemed disposal of its International Business (dilution of interest in the Target Company from 100% to 49%).
• Legal Action: After a special investigation, the Company commenced legal proceedings to unwind the Restructuring, citing deliberate omission of revenues and profits from Egypt and Lebanon to avoid triggering shareholder approval requirements for a major transaction.
• Potential Misconduct: The investigation uncovered that previous management may have acted to lower size test ratios below 25% by carving out certain businesses, thus circumventing more stringent Listing Rules and avoiding shareholder scrutiny.
• Further Legal Steps: Additional legal proceedings were initiated to obtain financial statements from the Target Company, and the Company has committed to further announcements as the situation develops.

2.2. Independent Investigations and Internal Control Review

• Investigation Findings: Two major investigation reports (by Grant Thornton Advisory) were completed in 2025 and early 2026, highlighting:
  • Insufficient basis for continued consolidation of the International Business post-restructuring.
  • Deliberate exclusion of revenues and profits from certain businesses to manipulate transaction size tests.
  • Improper or incomplete disclosure of related party transactions and purchase of financial products exceeding 5% of total assets without required disclosure.
  • Improperly authorised use of financial funds, including interest-free borrowings to directors, and expenditures benefiting entities controlled by related parties.
  • Concerns around the independence of legal advice received by the Company during the Restructuring process.
• Remedial Actions:
  • Appointment of an internal control consultant (BT Corporate Governance Limited) to thoroughly review and overhaul internal control systems.
  • Implementation of new policies on notifiable and connected transactions, credit management, documentation, and financial reporting.
  • Board acceptance of the need for restatement or changes to financial statements related to the consolidation issue.

2.3. Auditor Disclaimer of Opinion

• The auditor, Grant Thornton Hong Kong Limited, issued a disclaimer of opinion on the 2024 consolidated financial statements, citing the inability to obtain sufficient audit evidence concerning critical accounting matters, including the consolidation of the International Business, internal control weaknesses, and the impact of ongoing legal proceedings and investigations.
• This disclaimer is a serious concern and may have a significant negative impact on investor confidence and the Company’s future access to capital markets.

2.4. Connected Transactions and Related Party Dealings

• Several past connected transactions were found to have not been properly disclosed or approved under Listing Rules, including transactions with entities controlled by former directors and substantial shareholders.
• All such transactions have ceased, and the Company has committed to remedial measures to prevent recurrence.

2.5. Changes in Major Shareholdings

• Major changes in shareholdings were noted, with the controlling stakes of certain directors and their spouses being sold in early 2025. These changes may affect control and governance dynamics.

2.6. Dividend Out of Share Premium

• The 2023 dividend was paid out of the share premium account, as the profit attributable to equity holders was insufficient to cover the distribution. This practice, while legal under Cayman law, may be viewed as unsustainable if underlying profitability does not improve.

3. Internal Control and Governance Enhancements

• Following severe findings in the investigation reports, the Board and management have implemented a comprehensive internal control overhaul, including:
  • New written policies on notifiable and connected transactions to comply with Listing Rules.
  • Strengthened credit management, documentation requirements, and internal approval processes.
  • Appointment of an internal control consultant and ongoing monitoring by the Board.
• The Board asserts that, following these measures, the Group now maintains an adequate and effective system of internal controls to mitigate business risks and ensure regulatory compliance.

4. Risks and Uncertainties

• Ongoing Trading Suspension: Trading in the Company’s shares remains suspended, with a risk of delisting if public float is not restored within 18 months.
• Litigation and Restatements: Ongoing legal proceedings and the potential need to restate financial statements create material uncertainty for shareholders.
• Regulatory Investigation and Compliance: The Company remains subject to Resumption Guidance from the Stock Exchange, and failure to comply could jeopardize its listing status.
• Sector and Customer Concentration: The Company’s business is exposed to high customer concentration and sector-specific risks, which may be exacerbated by the current governance and financial uncertainties.

5. Investor Takeaways and Potential Share Price Impact

• High Price Sensitivity: The combination of auditor disclaimer, ongoing investigations, trading suspension, legal actions, and possible financial restatements are all highly price-sensitive events. These issues raise significant uncertainty regarding the Company’s financial position, governance, and future prospects.
• Trading Suspension and Delisting Risks: The inability to restore public float could result in prolonged trading suspension or even delisting, severely impacting liquidity and shareholder value.
• Dividend Sustainability: While the Company has paid dividends, questions remain about the sustainability of such distributions given underlying profitability and auditor concerns.
• Improvement Measures: The Company has responded with internal control enhancements and legal actions to unwind problematic transactions, but it remains to be seen whether these measures will restore market confidence and regulatory compliance in the near term.

6. Next Steps and Outlook

• The Company will continue to update shareholders as investigations, legal proceedings, and internal control improvements progress.
• Investors should closely monitor Company announcements regarding trading resumption, public float restoration, and any further financial restatements or legal outcomes.

Disclaimer:

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any securities. Investors should conduct their own research and consult professional advisers before making any investment decisions. The Company is subject to ongoing risks, regulatory actions, and uncertainties that may materially affect its financial condition and share price.

View GAPACK Historical chart here